Item Type | Name |
Concept
|
Lymphoma, B-Cell
|
Concept
|
Lymphoma, T-Cell
|
Concept
|
Lymphoma, T-Cell, Cutaneous
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
Concept
|
Lymphoma, B-Cell, Marginal Zone
|
Concept
|
Lymphoma, Mantle-Cell
|
Academic Article
|
A look at the National Comprehensive Cancer Network guidelines for cutaneous lymphomas.
|
Academic Article
|
Diffuse Large B-Cell Lymphoma Version 1.2016.
|
Academic Article
|
The state of cutaneous lymphomas: a call to action.
|
Academic Article
|
CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
|
Academic Article
|
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.
|
Academic Article
|
Periocular cutaneous anaplastic large cell lymphoma clearance with brentuximab vedotin.
|
Academic Article
|
Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma.
|
Academic Article
|
Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response.
|
Academic Article
|
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
|
Academic Article
|
We should have a dream: unlocking the workings of the genome in cutaneous T-cell lymphomas.
|
Academic Article
|
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
|
Academic Article
|
Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
|
Academic Article
|
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901.
|
Academic Article
|
Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
|
Academic Article
|
Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
|
Academic Article
|
New targets of therapy in T-cell lymphomas.
|
Academic Article
|
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.
|
Academic Article
|
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.
|
Academic Article
|
High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
|
Academic Article
|
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.
|
Academic Article
|
Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders.
|
Academic Article
|
Extranodal Marginal Zone Lymphoma-like Presentations of Angioimmunoblastic T-Cell Lymphoma: A T-Cell Lymphoma Masquerading as a B-Cell Lymphoproliferative Disorder.
|
Academic Article
|
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma.
|
Academic Article
|
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas.
|
Academic Article
|
A positive randomised trial in cutaneous T-cell lymphoma.
|
Academic Article
|
Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
|
Academic Article
|
Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
|
Academic Article
|
Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.
|
Academic Article
|
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
|
Academic Article
|
Treating cutaneous T-cell lymphoma with highly irregular surfaces with photon irradiation using rice as tissue compensator.
|
Academic Article
|
Activity of the PI3K-d,? inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
|
Academic Article
|
Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
|
Academic Article
|
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.
|
Academic Article
|
Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.
|
Academic Article
|
Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma.
|
Academic Article
|
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
|
Academic Article
|
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
|
Academic Article
|
Early CTCL diagnosis, a (miR)age no more?
|
Academic Article
|
Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
|
Academic Article
|
SĂ©zary Syndrome: Clinical and Biological Aspects.
|
Academic Article
|
Targeting the Bcl-2 Family in B Cell Lymphoma.
|
Academic Article
|
Expanding and expounding the genomic map of CTCL.
|
Academic Article
|
Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
|
Academic Article
|
Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
|
Academic Article
|
Cutaneous mantle cell lymphoma: a clinicopathologic review of 10 cases.
|
Academic Article
|
Preclinical Targeting of MicroRNA-214 in Cutaneous T-cell Lymphoma (CTCL).
|
Academic Article
|
The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy.
|
Academic Article
|
Emerging insights on the biology and treatment of cutaneous T-cell lymphoma.
|
Academic Article
|
Cutaneous CD4+ CD56+ hematologic malignancies.
|
Academic Article
|
Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases.
|
Academic Article
|
Systemic therapy of cutaneous T-cell lymphoma (CTCL).
|
Academic Article
|
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
|
Academic Article
|
Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations.
|
Academic Article
|
Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL).
|
Academic Article
|
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study.
|
Academic Article
|
Improved outcomes for extranodal natural killer T-cell lymphoma.
|
Academic Article
|
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.
|
Academic Article
|
Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial.
|
Academic Article
|
Profiling is a good thing (at least in the clinic).
|
Academic Article
|
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.
|
Academic Article
|
A case series of primary cutaneous B-cell lymphomas with atypical presentations: diagnostic and therapeutic Challenges.
|
Academic Article
|
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
|
Academic Article
|
Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. Case report.
|
Academic Article
|
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor.
|
Academic Article
|
Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma.
|
Academic Article
|
Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.
|
Academic Article
|
Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry.
|
Academic Article
|
Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities.
|
Academic Article
|
Front-line Chemo-immunotherapy with Nivolumab and Dose-Adjusted EPOCH in Peripheral T-cell Lymphoma: A Phase I Trial.
|
Academic Article
|
Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis.
|
Academic Article
|
Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
|
Academic Article
|
Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma.
|
Academic Article
|
XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.
|
Academic Article
|
The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual.
|
Academic Article
|
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.
|